Citi Sticks to Their Hold Rating for CSL (CMXHF)

Citi analyst Laura Sutcliffe maintained a Hold rating on CSL today and set a price target of A$160.00.

According to TipRanks, Sutcliffe is a 3-star analyst with an average return of 1.3% and a 50.29% success rate. Sutcliffe covers the Healthcare sector, focusing on stocks such as CSL, Telix Pharmaceuticals, and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh.

In addition to Citi, CSL also received a Hold from Canaccord Genuity’s Shane Storey in a report issued on September 4. However, on September 2, Morgan Stanley maintained a Buy rating on CSL (Other OTC: CMXHF).

CMXHF market cap is currently A$83.08B and has a P/E ratio of -23.43.